A randomised phase II trial and feasibility study of palliative chemotherapy in frail or elderly patients with advanced gastroesophageal cancer (321GO) by Hall, P, Lord, S, Collinson, M, Marshall, H, Jones, M, Lowe, C, Howard, H, Swinson, D, Velikova, G, Anthoney, A, Roy, R, Dent, J, Cheeseman, S, Last, K, Seymour, M

Capecitabine and streptozocin ± cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial by Meyer, T, Qian, W, Valle, J, Talbot, D, Cunningham, D, Reed, N, Wall, L, Waters, J, Ross, P, Anthoney, A, Sumpter, K, Sarwar, N, Crosby, T, Begum, N, Young, G, Hardy, R, Corrie, P

Clinical grade OK432-activated dendritic cells: in vitro characterization and tracking during intralymphatic delivery. by West, E, Morgan, R, Scott, K, Merrick, A, Lubenko, A, Pawson, D, Selby, P, Hatfield, P, Prestwich, R, Fraser, S, Eves, D, Anthoney, A, Twelves, C, Beirne, D, Patel, P, O'Donnell, D, Watt, S, Waller, M, Dietz, A, Robinson, P, Melcher, A

Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 pe... by Neoptolemos, J, Moore, M, Cox, T, Valle, J, Palmer, D, McDonald, A, Carter, R, Tebbutt, N, Dervenis, C, Smith, D, Glimelius, B, Charnley, R, Lacaine, F, Scarfe, A, Middleton, MR, Anthoney, A, Ghaneh, P, Halloran, C, Lerch, M, Oláh, A, Rawcliffe, C, Verbeke, C, Campbell, F, Büchler, M

Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial. by Greenhalf, W, Ghaneh, P, Neoptolemos, J, Palmer, D, Cox, T, Lamb, R, Garner, E, Campbell, F, Mackey, JR, Costello, E, Moore, M, Valle, J, McDonald, A, Carter, R, Tebbutt, N, Goldstein, D, Shannon, J, Dervenis, C, Glimelius, B, Deakin, M, Charnley, R, Lacaine, F, Scarfe, A, Middleton, MR, Anthoney, A